Alpha Tau Medical Ltd.
General ticker "DRTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $464.0M (TTM average)
Alpha Tau Medical Ltd. follows the US Stock Market performance with the rate: 60.3%.
Estimated limits based on current volatility of 2.5%: low 14.00$, high 14.72$
Factors to consider:
- Total employees count: 88 as of 2021
- Current price 111.4% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.85$, 6.78$]
- 2026-12-31 to 2027-12-31 estimated range: [2.15$, 5.35$]
Short-term DRTS quotes
Long-term DRTS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $35.68MM | $36.04MM | $42.29MM |
| Operating Income | $-35.68MM | $-36.04MM | $-42.29MM |
| Non-Operating Income | $6.54MM | $4.30MM | $-0.22MM |
| Interest Expense | $0.07MM | $0.30MM | $0.42MM |
| R&D Expense | $26.42MM | $27.02MM | $30.83MM |
| Income(Loss) | $-29.14MM | $-31.74MM | $-42.51MM |
| Taxes | $0.02MM | $0.01MM | $0.12MM |
| Net Income(Loss)* | $-29.16MM | $-31.75MM | $-42.63MM |
| Stockholders Equity | $84.47MM | $62.67MM | $77.10MM |
| Assets | $107.39MM | $86.20MM | $106.58MM |
| Operating Cash Flow | $-17.96MM | $-19.78MM | $-26.68MM |
| Capital expenditure | $6.40MM | $2.24MM | $6.08MM |
| Investing Cash Flow | $18.68MM | $20.77MM | $-20.59MM |
| Financing Cash Flow | $5.30MM | $0.03MM | $45.77MM |
| Earnings Per Share** | $-0.42 | $-0.45 | $-0.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.